|
Market Closed -
Bombay S.E.
06:02:22 2026-09-01 am EDT
|
5-day change | 1st Jan Change | ||
| 2,994.70 INR | -1.91% |
|
+2.19% | +21.20% |
| Aug. 03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| Aug. 03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.44B | - | - | |||
| 1,031B | |||||
| 641B | - | - | - | ||
| 453B | |||||
| 349B | |||||
| 290B |
Select your edition
All financial news and data tailored to specific country editions
